Cordasco Financial Network’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$3K Sell
9
-145
-94% -$38.8K ﹤0.01% 517
2022
Q1
$40K Buy
+154
New +$36.5K 0.03% 223
2021
Q3
Sell
-125
Closed -$25K 581
2021
Q2
$25K Buy
+125
New +$26.1K 0.02% 275

Other funds holding VRTX

Cordasco Financial Network's VRTX Position: Q2 2022 in Review

Cordasco Financial Network reduced its Vertex Pharmaceuticals (VRTX) stake by 94% in Q2 2022, selling an estimated $38.8K and leaving 9 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #517.

Cordasco Financial Network first reported a position in VRTX in Q2 2021 and has held it in 3 quarters since. The position peaked at $40K in Q1 2022. 1,107 funds tracked by Wall St. Rank hold VRTX as of Q2 2022.

  • Cordasco Financial Network held 9 shares of Vertex Pharmaceuticals worth $3K as of Q2 2022.
  • Cordasco Financial Network sold 145 Vertex Pharmaceuticals shares in Q2 2022, an estimated $38.8K.
  • Vertex Pharmaceuticals made up ﹤0.01% of Cordasco Financial Network's portfolio in Q2 2022, its #517 holding.
  • Cordasco Financial Network first reported a position in Vertex Pharmaceuticals in Q2 2021 and has held it in 3 quarters since.
  • Cordasco Financial Network's Vertex Pharmaceuticals position peaked at $40K in Q1 2022.
  • 1,107 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2022.

Based on Cordasco Financial Network's 13F filing for Q2 2022, filed 15 Jul 2022.